Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Terbinafine topical - Celtic Pharma

Next Previous
Drug Profile

Terbinafine topical - Celtic Pharma

Alternative Names: IDEA-067; TDT-067; Terbinafine cutaneous suspension

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator IDEA
  • Developer Celtic Pharma
  • Class Amines; Antifungals; Carrier proteins; Naphthalenes; Skin disorder therapies; Small molecules
  • Mechanism of Action Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Onychomycosis

Most Recent Events

  • 11 May 2015 No recent reports on development identified - Phase-III for Onychomycosis in USA, Iceland and Germany (Topical)
  • 30 Jun 2012 Celtic Pharma completes a phase II trial for Onychomycosis in USA (NCT01790165)
  • 13 Jan 2012 Celtic Pharma completes a phase III trial in Onychomycosis in USA, Germany & Iceland (NCT01145807)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top